ALPK1 Human Pre-designed siRNA Set A contains three designed siRNAs for ALPK1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ALPK2 Human Pre-designed siRNA Set A contains three designed siRNAs for ALPK2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ALPK3 Human Pre-designed siRNA Set A contains three designed siRNAs for ALPK3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ALPL Human Pre-designed siRNA Set A contains three designed siRNAs for ALPL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ALPP Human Pre-designed siRNA Set A contains three designed siRNAs for ALPP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Alprenolol (hydrochloride) (Standard) is the analytical standard of Alprenolol (hydrochloride). This product is intended for research and analytical applications. Alprenolol ((RS)-Alprenolol; dl-Alprenolol) hydrochloride is an orally active non-selective β-adrenoceptor antagonist and an antagonist of 5-HT1A and 5-HT1B receptors. Alprenolol hydrochloride is used as an anti-hypertensive, anti-anginal and anti-arrhythmic agent[1][2][3].

ALS2 Human Pre-designed siRNA Set A contains three designed siRNAs for ALS2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ALS2CL Human Pre-designed siRNA Set A contains three designed siRNAs for ALS2CL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ALX1 Human Pre-designed siRNA Set A contains three designed siRNAs for ALX1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ALX3 Human Pre-designed siRNA Set A contains three designed siRNAs for ALX3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ALX4 Human Pre-designed siRNA Set A contains three designed siRNAs for ALX4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ALYREF Human Pre-designed siRNA Set A contains three designed siRNAs for ALYREF gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AM4085 is an orally active Antagonist for FmlH with an IC50 of 0.19 μM. AM4085 reveals metabolic stability in mouse liver microsomes and blood plasma[1].

AMACR Human Pre-designed siRNA Set A contains three designed siRNAs for AMACR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Amantadine-d15 hydrochloride is deuterated labeled Amantadine. Amantadine (1-Adamantanamine) is an orally avtive and potent antiviral agent with activity against influenza A viruses. Amantadine inhibits several ion channels such as NMDA and M2, and also inhibits Coronavirus ion channels. Amantadine also has anti-orthopoxvirus and anticancer activity. Amantadine can be used for Parkinson’s disease, postoperative cognitive dysfunction […]

Amaranth free acid (Acid Red 27 free acid; Azorubin S free acid; FD & C Red Dye No. 2 free acid) is a multifunctional dye. Dyes are important tools in biological experiments. They can help researchers observe and analyze cell structures, track biomolecules, evaluate cell functions, distinguish cell types, detect biomolecules, study tissue pathology and […]

AMBN Human Pre-designed siRNA Set A contains three designed siRNAs for AMBN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AMBP Human Pre-designed siRNA Set A contains three designed siRNAs for AMBP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AMBRA1 Human Pre-designed siRNA Set A contains three designed siRNAs for AMBRA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ambroxol (hydrochloride) (Standard) is the analytical standard of Ambroxol (hydrochloride). This product is intended for research and analytical applications. Ambroxol hydrochloride (NA-872 hydrochloride), an active metabolite of the proagent Bromhexine, has potent expectorant effects. Ambroxol hydrochloride is a glucocerebrosidase (GCase) chaperone and increases glucocerebrosidase activity. Ambroxol hydrochloride induces lung autophagy and has the potential for […]

Ambruticin (W7783) is an orally active and potent antifungal antibiotic. Ambruticin represents a class of antibiotics, that can be isolated from a strain of Polyangium cellulosum var. fulvum, a bacterium belonging to the class Myxobacteriales. Ambruticin is a cyclopropyl-polyene-pyran acid and is active against fungi[1].

AMC-04 is an unfolded protein response (UPR) activator, which activates UPR pathway through ROS and p38 MAPK signaling and induces apoptotic cell death. AMC-04 can be used for cancer research[1].

AMD1 Human Pre-designed siRNA Set A contains three designed siRNAs for AMD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AMDHD1 Human Pre-designed siRNA Set A contains three designed siRNAs for AMDHD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AMDHD2 Human Pre-designed siRNA Set A contains three designed siRNAs for AMDHD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NX-13 is a first-in-class, orally active and gut-restricted agent that selectively targets and activates the NLRX1 pathway to induce immunometabolic changes. NX-13 results in lower inflammation and responses in inflammatory bowel disease. NX-13 can be used for the research of crohn’s disease and ulcerative colitis[1][2].

NX-13 is a first-in-class, orally active and gut-restricted agent that selectively targets and activates the NLRX1 pathway to induce immunometabolic changes. NX-13 results in lower inflammation and responses in inflammatory bowel disease. NX-13 can be used for the research of crohn’s disease and ulcerative colitis[1][2].

NX-13 is a first-in-class, orally active and gut-restricted agent that selectively targets and activates the NLRX1 pathway to induce immunometabolic changes. NX-13 results in lower inflammation and responses in inflammatory bowel disease. NX-13 can be used for the research of crohn’s disease and ulcerative colitis[1][2].

NX-13 is a first-in-class, orally active and gut-restricted agent that selectively targets and activates the NLRX1 pathway to induce immunometabolic changes. NX-13 results in lower inflammation and responses in inflammatory bowel disease. NX-13 can be used for the research of crohn’s disease and ulcerative colitis[1][2].

NX-13 is a first-in-class, orally active and gut-restricted agent that selectively targets and activates the NLRX1 pathway to induce immunometabolic changes. NX-13 results in lower inflammation and responses in inflammatory bowel disease. NX-13 can be used for the research of crohn’s disease and ulcerative colitis[1][2].

Amelparib (JPI-289) hydrochloride is a potent, orally active, and water-soluble inhibitor of PARP-1. Amelparib hydrochloride inhibits PARP-1 activity (IC50 = 18.5 nM) and cellular PAR formation (IC50 = 10.7 nM). Amelparib hydrochloride is a potential neuroprotective agent. Amelparib hydrochloride has the potential for the research of acute ischaemic stroke[1].

Amelparib (JPI-289) hydrochloride is a potent, orally active, and water-soluble inhibitor of PARP-1. Amelparib hydrochloride inhibits PARP-1 activity (IC50 = 18.5 nM) and cellular PAR formation (IC50 = 10.7 nM). Amelparib hydrochloride is a potential neuroprotective agent. Amelparib hydrochloride has the potential for the research of acute ischaemic stroke[1].

Amelparib (JPI-289) hydrochloride is a potent, orally active, and water-soluble inhibitor of PARP-1. Amelparib hydrochloride inhibits PARP-1 activity (IC50 = 18.5 nM) and cellular PAR formation (IC50 = 10.7 nM). Amelparib hydrochloride is a potential neuroprotective agent. Amelparib hydrochloride has the potential for the research of acute ischaemic stroke[1].

AMELX Human Pre-designed siRNA Set A contains three designed siRNAs for AMELX gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AMELY Human Pre-designed siRNA Set A contains three designed siRNAs for AMELY gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AMER1 Human Pre-designed siRNA Set A contains three designed siRNAs for AMER1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AMER2 Human Pre-designed siRNA Set A contains three designed siRNAs for AMER2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AMER3 Human Pre-designed siRNA Set A contains three designed siRNAs for AMER3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Amfenac-d5 sodium is deuterated-labeled Amfenac.

Amfenac-d5 sodium is deuterated-labeled Amfenac.

Amfenac-d5 sodium is deuterated-labeled Amfenac.

AMFR Human Pre-designed siRNA Set A contains three designed siRNAs for AMFR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AMH Human Pre-designed siRNA Set A contains three designed siRNAs for AMH gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AMHR2 Human Pre-designed siRNA Set A contains three designed siRNAs for AMHR2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.